Natsimbio Becomes Main Sponsor of 2023 GxP-Profi Awards

Natsimbio, part of Russia’s Rostec State Corporation, brings together large biopharma enterprises that develop, manufacture and sell biopharmaceuticals. The company also supplies vaccines all across the country. Its consolidated product portfolio features over 220 items of medicines and diagnostic products. As a manufacturer and supplier of vaccines, Natsimbio holds about 90% of Russia’s National Vaccination Schedule. Every year, it supplies on average 20 different kinds of domestically produced vaccines. The National Vaccination Schedule partner since 2015, the company has provided the regions with over 1bn vaccine doses. This year marks Natsimbio’s 10th anniversary.
In August, the company successfully underwent an independent QMS audit, which confirmed its compliance with the requirements of Russia’s GOST R ISO 9001-2015 and the ISO 9001:2015 standards. The audited areas included procurement, storage, transportation and sales of medicines and medical products. ‘Our compliance with both national and international requirements is yet another proof of how much attention we pay to ensuring the quality of our products and services. And that is why we have become the main sponsor of the 2023 professional excellence awards GxP-Profi’, says Natsimbio.
The event is designed to foster the potential of Russia’s pharma industry by developing and implementing innovative GxP solutions. The goals of GxP-Profi include identifying quality assurance leaders among the EAEU pharmaceutical manufacturers, promoting the best innovative solutions in the industry, enhancing the image of the EAEU pharma companies, and boosting their competitive advantage in the global market.